Medical advancements improve prevention of cervical and ovarian cancers

Medical advancements are improving the prevention and detection of gynecological cancers, specifically cervical and ovarian cancers. Human Papillomavirus (HPV) is responsible for over 95% of cervical cancer cases. While most HPV infections are cleared by the immune system within two years, persistent high-risk infections can lead to precancerous lesions over a period of 10 to 20 years. Modern testing methods, including Pap tests and HPV tests, allow for early detection during routine gynecological exams.

Regarding ovarian cancer, surgeon David Cibula notes that while often diagnosed at advanced stages, symptoms such as abdominal swelling can serve as warning signs. A significant breakthrough in managing ovarian cancer risk is genetic testing for BRCA gene mutations. Identifying these mutations allows doctors to locate high-risk families and potentially prevent the disease before it develops. Genetic testing is particularly recommended for women with a family history of cancer or those diagnosed with breast cancer at a young age.